ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,103,000 | -29.5% | 52,036 | +0.4% | 0.47% | -24.8% |
| Q2 2015 | $2,983,000 | -6.8% | 51,831 | +3.1% | 0.62% | -7.0% |
| Q1 2015 | $3,201,000 | +2.7% | 50,275 | -0.4% | 0.67% | +1.2% |
| Q4 2014 | $3,116,000 | +58.4% | 50,465 | -0.4% | 0.66% | +55.1% |
| Q3 2014 | $1,967,000 | -41.3% | 50,655 | -47.9% | 0.42% | -40.6% |
| Q2 2014 | $3,351,000 | -20.6% | 97,260 | -0.5% | 0.72% | -23.0% |
| Q1 2014 | $4,223,000 | +10.8% | 97,725 | +2.1% | 0.93% | +1.9% |
| Q4 2013 | $3,812,000 | -0.7% | 95,695 | -6.5% | 0.91% | -9.8% |
| Q3 2013 | $3,840,000 | +38.9% | 102,294 | -0.6% | 1.01% | +31.6% |
| Q2 2013 | $2,765,000 | – | 102,890 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |